Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
1988-5-2
|
pubmed:abstractText |
The present information relative to hyperprolactinemia is designed to give the reader insight into the possible central abnormalities occurring in women with elevated prolactin levels. It appears that in the presence of elevated prolactin levels appropriate testing should evaluate the pituitary gland, and that this should be performed in association with thyroid function studies. The treatment of high prolactin levels is mainly based on the clinical findings, but in most of the instances, a medical approach utilizing bromocriptine appears to be advantageous. Long-term results appear to indicate that bromocriptine is effective with a wide margin of safety.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
0889-8545
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
14
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
979-98
|
pubmed:dateRevised |
2005-11-16
|
pubmed:meshHeading | |
pubmed:year |
1987
|
pubmed:articleTitle |
Current concepts and treatment of hyperprolactinemia.
|
pubmed:affiliation |
Jones Institute for Reproductive Medicine, Department of Obstetrics and Gynecology, Eastern Virginia Medical School, Norfolk.
|
pubmed:publicationType |
Journal Article,
Review
|